Clinigen to distribute Etopophos, Vepesid in Australia and NZ
Australia | News | 0 Comment | 03 Sep, 2019
Clinigen Group plc, the global pharmaceutical and services company, and CHEPLAPHARM Arzneimittel GmbH (‘CHEPLAPHAR...Read more
THC Global Groups' Australalia's Facility Opened by Federal Minister for Health
Australia | News | 0 Comment | 22 Aug, 2019
THC Global Group Limited (THC Global or the Company) has announced that its Southport Facility was opened by the Federal...Read more
Hand held device for predicting heart failure based on saliva
Australia | News | 0 Comment | 28 Aug, 2019
Nano-sensors on the tip of the diagnostic stick measure heart disease biomarkers to accurately predict the risk of heart...Read more
Microba partners with Microbiome Research Centre to deliver world-class analysis
Australia | News | 0 Comment | 27 Aug, 2019
Australia’s leading gut microbiome testing specialists Microba have partnered with the Microbiome Research Centre ...Read more
Australian scientists develop new vaccine for TB
Australia | News | 0 Comment | 27 Aug, 2019
Australian medical researchers from the Centenary Institute and the University of Sydney have successfully developed and...Read more
Evado is proud to announce the launch of Evado eConsent.
Australia | News | 0 Comment | 22 Aug, 2019
eConsent App The Evado eConsent App is targeted at any health related organisation that needs to record patient c...Read more
Australia's Propanc Biopharma gets US Patent
Australia | News | 0 Comment | 23 Aug, 2019
Melbourne based Propanc Biopharma Inc., a biopharmaceutical company developing new cancer treatments for patients suffer...Read more
Q-Sera’s Blood Clotting Technology Granted Patent in US
Australia | News | 0 Comment | 21 Aug, 2019
Australia based Medical device company Q-Sera Pty Ltd has announced that it has received a Notice of Allowance from the ...Read more
GE Healthcare partnership takes aim at Brain Aneurysms with AI
Australia | News | 0 Comment | 13 Aug, 2019
GE Healthcare, Fujitsu Australia, Macquarie University and Macquarie Medical Imaging has announced a new research collab...Read more
The iQ Group Global stands among 5 most Innovative companies 2019
Australia | News | 0 Comment | 12 Aug, 2019
The iQ Group Global is honoured to be recognised as one of Australia and New Zealand's Top...Read more
ANDHealth joins leading institutes to drive digital healthcare
Australia | News | 0 Comment | 09 Aug, 2019
Leading medical research institutes and universities in Western Australia have announced a new partnership with ANDHealt...Read more
Global Diagnostics Australia Incorporates AI into Radiology Applications
Australia | News | 0 Comment | 08 Aug, 2019
Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has announced that it has adop...Read more
SpeeDx secures $15M from US investment partnership
Australia | News | 0 Comment | 07 Aug, 2019
SpeeDx Pty. Ltd., an Australia based developer of disruptive new molecular diagnostic solutions has announced that it ha...Read more
TGA approves new drug for diabetes induced vision loss
Australia | News | 0 Comment | 06 Aug, 2019
Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and...Read more
Chemist Warehouse to provide affordable orthodontic clear aligner therapy
Australia | News | 1 Comment | 05 Aug, 2019
Chemist Warehouse, on 5 August 2019, announced its partnership with SmileDirectClub, the US-based&nb...Read more
Botanix receives commitments for A$40M in US-led institutional placement
Australia | News | 0 Comment | 05 Aug, 2019
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...Read more
Biocon, Mylan launch Ogivri in Australia
Australia | News | 0 Comment | 02 Aug, 2019
Biocon Ltd. and Mylan N.V. have announced the launch in Australia of Ogivri™ (trastuzumab), a biosimilar...Read more
Alterity Therapeutics announces successful completion of Phase 1 Clinical Trial
Australia | News | 0 Comment | 31 Jul, 2019
Alterity Therapeutics Limited has announced that it has successfully completed its Phase 1 study of PBT434, a novel, ora...Read more